Royal Bank of Canada
HSCS icon

Royal Bank of Canada’s Heart Test Laboratories HSCS Stock Holding History

Royal Bank of Canada’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-860
Closed -$78K – 7290
2023
Q2 		$78K Hold
860
– – ﹤0.01% 5519
2023
Q1 		$85K Buy
+860
New +$116K ﹤0.01% 5301

Other funds holding HSCS

TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada's HSCS Position: Q3 2023 in Review

Royal Bank of Canada sold out of Heart Test Laboratories (HSCS) in Q3 2023, closing a stake of 860 shares — an estimated $78K sold.

Royal Bank of Canada first reported a position in HSCS in Q1 2023 and held it in 2 quarters. The position peaked at $85K in Q1 2023. 10 funds tracked by Wall St. Rank hold HSCS as of Q3 2023.

  • Royal Bank of Canada reported no remaining Heart Test Laboratories position as of Q3 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 860 Heart Test Laboratories shares in Q3 2023, an estimated $78K.
  • Royal Bank of Canada first reported a position in Heart Test Laboratories in Q1 2023 and held it in 2 quarters.
  • Royal Bank of Canada's Heart Test Laboratories position peaked at $85K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.